Crestline Management, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 205 filers reported holding HERON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Crestline Management, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,696,000
+54.3%
185,766
+80.6%
0.13%
+23.3%
Q3 2021$1,099,000
-62.6%
102,845
+36.0%
0.10%
-66.7%
Q2 2018$2,939,000
+17.1%
75,645
-16.8%
0.31%
-1.0%
Q1 2018$2,509,000
+19.2%
90,916
-21.8%
0.31%
+44.4%
Q4 2017$2,105,000
+225.3%
116,290
+190.2%
0.22%
+140.0%
Q3 2017$647,000
+26.1%
40,078
+8.3%
0.09%
+30.4%
Q2 2017$513,00037,0200.07%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders